These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12931338)

  • 21. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 22. [HIV vaccination].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
    [No Abstract]   [Full Text] [Related]  

  • 23. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
    Petrovas C; Mueller YM; Katsikis PD
    Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
    [No Abstract]   [Full Text] [Related]  

  • 24. Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapy.
    Jursik C; Prchal M; Grillari-Voglauer R; Drbal K; Fuertbauer E; Jungfer H; Albert WH; Steinhuber E; Hemetsberger T; Grillari J; Stockinger H; Katinger H
    Mol Cancer Res; 2009 Mar; 7(3):339-53. PubMed ID: 19240181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.
    Trzonkowski P; Szmit E; Myśliwska J; Dobyszuk A; Myśliwski A
    Clin Immunol; 2004 Sep; 112(3):258-67. PubMed ID: 15308119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
    Egan MA
    Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary: T cells get by with a little help from their friends.
    Klenerman P
    Eur J Immunol; 2004 Feb; 34(2):313-6. PubMed ID: 14768035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?
    Draenert R; Goebel FD
    Infection; 2004 Aug; 32(4):250-2. PubMed ID: 15293085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.
    Hultström AL; Bratt G; Cosma A; Erfle V; Wahren B; Carbone E
    Immunol Lett; 2004 Feb; 91(2-3):155-8. PubMed ID: 15019284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
    Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
    J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of infants coinfected with HIV-1 and cytomegalovirus with combination antiretrovirals and ganciclovir.
    Saitoh A; Viani RM; Schrier RD; Spector SA
    J Allergy Clin Immunol; 2004 Oct; 114(4):983-5. PubMed ID: 15480350
    [No Abstract]   [Full Text] [Related]  

  • 36. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cells, human cytomegalovirus and end-stage renal disease.
    Wang EC
    Nephrol Dial Transplant; 2011 May; 26(5):1467-70. PubMed ID: 21460358
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxic lymphocytes for the clinic.
    Barrett AJ; Sharp JG
    Cytotherapy; 2006; 8(2):93-4. PubMed ID: 16698682
    [No Abstract]   [Full Text] [Related]  

  • 40. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.